News Industry News First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial July 14, 2021
News Industry News Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation June 24, 2019
News Industry News GORE® CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects June 04, 2019
News Industry News 4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec July 20, 2017
News Industry News 4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum June 16, 2017
News Industry News 4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum June 08, 2017